EX-99.2 5 ex99-2.htm EX-99.2

Exhibit 99.2

Fitters Unaudited Balance Sheet as of

|  | June 30, 2025 |  |  | June 30, 2024 |
|  | (in thousands) |
Current Assets |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 849 |  |  | $ | 301 |
Inventories |  |  | 1,593 |  |  |  | 1,363 |
Accounts receivables |  |  | 1,364 |  |  |  | 1,952 |
Deferred Tax |  |  | 75 |  |  |  | 26 |
Prepaid & other current assets |  |  | 1,048 |  |  |  | 819 |
|  |  | 4,930 |  |  |  | 4,461 |
Investments And Other Assets |  |  |  |  |  |  |  |
Property, plant and equipment, net |  |  | 107 |  |  |  | 110 |
ROU Asset |  |  | 429 |  |  |  | 409 |
Investment assets |  |  | 72 |  |  |  | 69 |
|  |  | 608 |  |  |  | 587 |
Total Assets |  | $ | 5,538 |  |  | $ | 5,049 |
Current Liabilities |  |  |  |  |  |  |  |
Trade payables |  | $ | 1,025 |  |  | $ | 725 |
Accrued and other current liabilities |  |  | 11 |  |  |  | 126 |
|  |  | 1,037 |  |  |  | 851 |
Non-current Liabilities |  |  |  |  |  |  |  |
Lease liability |  |  |  |  |  |  |  |
Deferred income tax liability |  |  |  |  |  |  |  |
|  |  | - |  |  |  | - |
Stockholders Equity |  |  |  |  |  |  |  |
Common Stock |  |  | 667 |  |  |  | 636 |
Preferred Stock |  |  |  |  |  |  |  |
Additional paid-in capital |  |  | - |  |  |  | - |
Accummulated other comprehensive loss |  |  | - |  |  |  | - |
Accummulated deficit |  |  | 3,835 |  |  |  | 3,562 |
Total Stockholders' Equity |  |  | 4,501 |  |  |  | 4,198 |
Total liabilities and stockholders' equity |  | $ | 5,538 |  |  | $ | 5,049 |

Fitters Unaudited Statement of Operations for the Three Months Ended

|  | June 30, 2025 |  |  | June 30, 2024 |
|  | (in thousands) |
Revenues |  |  |  |  |  |  |  |
Sales Revenue |  | $ | 501 |  |  | $ | 365 |
Clinical Trial Supply |  |  |  |  |  |  |  |
Revenues |  |  | 501 |  |  |  | 365 |
Cost of Sales |  |  | 415 |  |  |  | 294 |
General & administrative |  |  | 109 |  |  |  | 119 |
Research and development |  |  |  |  |  |  |  |
Operating Loss |  |  | (22 | ) |  |  | (48 | )
Other income (expense), net |  |  | 70 |  |  |  | 57 |
Loss before taxes |  |  | 47 |  |  |  | 9 |
Income tax benefit |  |  |  |  |  |  |  |
Income tax expense |  |  |  |  |  |  |  |
Net loss |  | $ | 47 |  |  | $ | 9 |
Basic and diluted earnings per common share: |  |  |  |  |  |  |  |
Net loss per share, continuing operations – basic and diluted |  | $ | 0.02 |  |  | $ | 0.00 |
Weighted average common shares outstanding - basic & diluted |  |  | 3,000,000 |  |  |  | 3,000,000 |